Department of Endocrinology and Metabolism, First Hospital of Jilin University, Changchun, Jilin, China.
Department of Orthopedics, The Second Hospital of Jilin University, Changchun, Jilin, China.
Front Endocrinol (Lausanne). 2023 May 22;14:1188972. doi: 10.3389/fendo.2023.1188972. eCollection 2023.
Observational studies have shown that sarcopenia and diabetic nephropathy (DN), are closely related; however, the causal relationship is unclear. This study aims to address this issue using a bidirectional Mendelian randomization (MR) study.
We data from genome-wide association studies including appendicular lean mass (n = 244,730), grip strength (right: n = 461,089, left: n = 461026), walking speed (n = 459,915), and DN (3283 cases and 181,704 controls) to conduct a bidirectional MR study. First, we conducted a Forward MR analysis to evaluate the causality of sarcopenia on the risk of DN from the genetic perspective with appendicular lean mass, grip strength, and walking speed as exposure and DN as the outcome. Then, DN as the exposure, we performed a Reverse MR analysis to determine whether DN impacted the appendicular lean mass, grip strength, and walking speed of the appendices. Finally, a series of sensitivity studies, such as heterogeneity tests, pleiotropy evaluations, and Leave-one-out analyses, were conducted to assess the MR analysis's accuracy further.
According to a forward MR analysis, a genetically predicted decrease in appendicular lean mass is associated with an increased risk of developing DN risk (inverse variance weighting[IVW]: odd ratio [OR] = 0.863, 95% confidence interval [CI] 0.767-0.971; P = 0.014). According to reverse MR results, grip strength decreased as DN progressed (IVW: right β = 0.003, 95% CI: - 0.021 to - 0.009, P = 5.116e-06; left β = 0.003, 95% CI: - 0.024 to - 0.012, P = 7.035e-09). However, the results of the other MR analyses were not statistically different.
Notably, our findings suggest that the causal relationship between sarcopenia and DN cannot be generalized. According to analysis of the individual characteristic factors of sarcopenia, reducing in appendicular lean mass increases the risk of developing DN and DN is linked to reduced grip strength. But overall, there is no causal relationship between sarcopenia and DN, because the diagnosis of sarcopenia cannot be determined by one of these factors alone.
观察性研究表明,肌少症与糖尿病肾病(DN)密切相关,但因果关系尚不清楚。本研究旨在通过双向孟德尔随机化(MR)研究来解决这个问题。
我们从全基因组关联研究中获取数据,包括四肢瘦质量(n=244730)、握力(右侧:n=461089,左侧:n=461026)、步行速度(n=459915)和 DN(3283 例病例和 181704 例对照),以进行双向 MR 研究。首先,我们进行了正向 MR 分析,从遗传角度评估肌少症对 DN 风险的因果关系,以四肢瘦质量、握力和步行速度作为暴露因素,以 DN 作为结局。然后,以 DN 作为暴露因素,我们进行了反向 MR 分析,以确定 DN 是否影响四肢的瘦质量、握力和步行速度。最后,进行了一系列敏感性研究,如异质性检验、多效性评估和单倍型分析,以进一步评估 MR 分析的准确性。
根据正向 MR 分析,遗传预测的四肢瘦质量下降与 DN 风险增加相关(逆方差加权[IVW]:比值比[OR] = 0.863,95%置信区间[CI] 0.767-0.971;P = 0.014)。根据反向 MR 结果,随着 DN 的进展,握力下降(IVW:右侧β=0.003,95%CI:-0.021 至-0.009,P=5.116e-06;左侧β=0.003,95%CI:-0.024 至-0.012,P=7.035e-09)。然而,其他 MR 分析的结果没有统计学差异。
值得注意的是,我们的研究结果表明,肌少症和 DN 之间的因果关系不能一概而论。根据肌少症个体特征因素的分析,四肢瘦质量的减少增加了发生 DN 的风险,DN 与握力下降有关。但总体而言,肌少症和 DN 之间没有因果关系,因为不能仅通过这些因素中的一个来确定肌少症的诊断。